| abstract |
In some aspects, the disclosure provides for treating, preventing, or reducing the rate and / or severity of kidney disease, particularly treating one or more kidney disease-related complications. Or activin and / or GDF antagonists and methods of using activin and / or GDF antagonists that reduce or reduce their rate of progression and / or severity. [Selection figure] None |